Clinical effect of anlotinib in combination with docetaxel in treating advanced
non-small cell lung cancer

Guibin Weng,; Weimin Fang,; Yijin Lin,; Lin Chen,; Weikun Su,

doi:10.14715/cmb/2024.70.4.33

Cell Mol Biol (Noisy-le-grand)

2024

DOI: 10.14715/cmb/2024.70.4.33

|View full text |Cite

Clinical effect of anlotinib in combination with docetaxel in treating advanced non-small cell lung cancer

Guibin Weng,

Weimin Fang,

Yijin Lin

et al.

Abstract: Materials and Methods General dataOne hundred patients with advanced NSCLC admitted to our hospital from January 2019 to December 2022 were retrospectively chosen to be the study objects, and separated into observation group (OG, n=50) and control group

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Publication Types

Select...

Relationship

Self Cite0

Independent0

Authors

Journals

Cited by 0 publications

References 25 publications

(25 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

No citations

Set email alert for when this publication receives citations?

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Clinical effect of anlotinib in combination with docetaxel in treating advanced non-small cell lung cancer

Abstract: Materials and Methods General dataOne hundred patients with advanced NSCLC admitted to our hospital from January 2019 to December 2022 were retrospectively chosen to be the study objects, and separated into observation group (OG, n=50) and control group

Cited by 0 publications

References 25 publications

No citations

Contact Info

Product

Resources

About